Nike (NKE) drops fiscal Q4 2026 results tomorrow after the close. Call starts at 2:00 p.m. PT. The stock is sitting near $40.75 — a 12-year low, down roughly 35% year to date. That context matters before you look at a single number in the release.

Here’s the thing. Everyone is going to focus on whether revenue comes in above or below the guided 2-4% year-over-year decline. That debate is almost beside the point. The company already told you revenue would be soft. What they could not fully tell you is where gross margin lands — and that is the only number that changes the stock’s story in either direction.

One wrinkle that got added to the mix on June 23: Nike pre-disclosed that Q4 results will include a tariff refund benefit. Size unknown. Management said strip it out and the underlying business should land broadly in line with prior guidance. So tomorrow has two readings — the headline number with the refund baked in, and what the business actually looks like without it. Investors will do that math in real time on the call, which makes the commentary more important than the release itself.

Where the margin story stands right now: gross margin compressed 130 basis points in Q3 to 40.2%. Tariffs in North America accounted for roughly 300 basis points of that pressure alone. Nike has paid approximately $1 billion in IEEPA tariffs. Management guided Q4 gross margin to decline another 25 to 75 basis points sequentially, with tariffs accounting for about 250 of those basis points. And here is the part that is easy to miss — margin expansion is not expected to begin until Q2 FY2027 at the earliest. That is a long runway of pressure before anything improves structurally.

If tomorrow’s gross margin lands at or above the high end of that guidance range, the stock has a credible path to a relief move toward $48-$52. If it misses the low end, North America wholesale progress will not matter. Not that day.

Slight tangent, but worth holding onto: the running category has grown more than 20% for three straight quarters through Q3. That is real. It is the clearest evidence that CEO Elliott Hill’s “Win Now” restructuring is doing something in the places where product actually matters. The issue is that Sportswear — a much bigger slice of the revenue base — is still declining double digits. So you have a brand with genuine momentum in one pocket and genuine deterioration in another, and the stock price reflects the weighted average of both.

China is the other conversation happening in parallel. Greater China revenue fell 7% on a reported basis to $1.62 billion in Q3 — the sixth consecutive quarterly decline. Management guided Q4 Greater China down approximately 20%, which sounds alarming but is partly intentional. Nike is actively pulling product from the channel to clean up inventory and protect pricing health. Whether that strategy is working, or whether underlying demand is weaker than the company is letting on, is something the call commentary will either clarify or further obscure. Analysts will push on it.

Then there’s the CFO change. David Denton joins as CFO effective August 17, replacing Matthew Friend, who stays through September 4 and will be on tomorrow’s call. Denton previously served as CFO at Pfizer. A CFO transition mid-restructuring, just ahead of a fall analyst day, is not a routine move. Investors will be listening closely to whether the capital allocation language shifts at all — buybacks, dividend, investment priorities. Any change in framing there will get noticed.

What analysts are expecting: consensus among 23 analysts sits at EPS of $0.12 on revenue of roughly $10.85 billion. That EPS estimate was $0.22 just three months ago. The range runs from $0.07 to $0.16, which tells you how wide the disagreement is. On price targets, Deutsche Bank holds at $43 (cut from $51), Goldman at $46 (cut from $52), Stifel at $50 (cut from $56), BTIG at $55 (cut from $75), Oppenheimer at $60 (cut from $120). KeyBanc dropped its price target entirely when it downgraded to Sector Weight from Overweight. Consensus average sits roughly in the $55-$59 range depending on the provider, but treat that number loosely — cuts have been coming in fast.

Technically, NKE just touched a fresh 52-week low of $40.00. The 52-week high is $80.17. The stock is trading at roughly half that. Momentum indicators are stretched into oversold territory, which can precede a bounce — but oversold and bottomed are two very different things. The level worth watching on a recovery is $46-$48. A sustained close above there suggests the near-term low is in. Below current levels, $36-$38 is the next real support.

What actually matters tomorrow, in order: gross margin guidance for Q1 FY2027 and whether the Q2 expansion timeline holds. Greater China revenue versus the approximately -20% guide — any outperformance there changes the tone fast. How management characterizes the tariff refund and separates it from underlying performance. Any language on FY2027 that goes beyond “we expect improvement” and into something investors can anchor to. And the CFO transition tone.

Nike is not a broken brand. It’s a brand paying the price for a strategic reset it chose, in a macro environment that did not cooperate, in a China market that is actively working against it. Most analysts still assume recovery happens. The disagreement is about when, and at what margin structure. Tomorrow either gives investors a real anchor for that timeline, or it does not. And right now, at $40.75, the market has already made its opinion pretty clear about how it expects this to go.